Here are three things to know about the agreement:
- Sasmar acquired all stock to the privately held biotech in exchange for an upfront payment of an undisclosed cash amount.
- Sasmar first partnered with Aquatrove in 2008 by commercializing the biotech’s patented fertility lubricant.
- The deal closed this week, officially transferring ownership of Aquatrove’s global portfolio of intellectual property, patents, and 14 years of research data to Sasmar.
More articles on supply chain:
Opioid overdose drug now offered over the counter at 96 Krogers in Kentucky
Study finds AstraZeneca’s FluMist vaccine effective, contradicts CDC
Are physicians and medical device reps too buddy-buddy?
